Abstract:Hepatocyte cell death and liver inflammation have been well recognized as central characteristics of nonalcoholic steatohepatitis (NASH), however, the underlying molecular basis remains elusive. The kinase receptor-interacting protein 1 (RIP1) is a multitasking molecule with distinct functions in regulating apoptosis, necroptosis, and inflammation. Dissecting the role of RIP1 distinct functions in different pathophysiology has absorbed huge research enthusiasm. Wild-type and RIP1 kinase-dead (Rip1K45A/K45A) mice were fed with high-fat diet (HFD) to investigate the role of RIP1 kinase activity in the pathogenesis of NASH. Rip1K45A/K45A mice exhibited significantly alleviated NASH phenotype of hepatic steatosis, liver damage, fibrosis as well as reduced hepatic cell death and inflammation compared to WT mice. Our results also indicated that both in vivo lipotoxicity and in vitro saturated fatty acids (palmitic acid) treatment were able to induce the kinase activation of RIP1 in liver macrophages. RIP1 kinase was required for mediating inflammasome activation, apoptotic and necrotic cell death induced by palmitic acid in both bone marrow-derived macrophage and mouse primary Kupffer cells. Results from chimeric mice established through lethal irradiation and bone marrow transplantation further confirmed that the RIP1 kinase in hematopoietic-derived macrophages contributed mostly to the disease progression in NASH. Consistent with murine models, we also found that RIP1 kinase was markedly activated in human NASH, and the kinase activation mainly occurred in liver macrophages as indicated by immunofluorescence double staining. In summary, our study indicated that RIP1 kinase was phosphorylated and activated mainly in liver macrophages in both experimental and clinical NASH. We provided direct genetic evidence that the kinase activity of RIP1 especially in hematopoietic-derived macrophages contributes to the pathogenesis of NASH, through mediating inflammasome activation and cell death induction. Macrophage RIP1 kinase represents a specific and potential therapeutic target for NASH.

Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway

Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis

Tyrosine Phosphorylation Regulates RIPK1 Activity to Limit Cell Death and Inflammation.

RIPK1 Biallelic Activating Variants lead to Autoinflammatory Disease Driven by T cell Death

Linear Ubiquitination of RIPK1 on Lys612 Regulates Systemic Inflammation via Preventing Cell Death.

Regulation of Cellular Apoptosis by Palmitic Acid and TNF‐alpha: Involvement of Signal Transduction Pathways from PKR to Bcl‐2

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages

The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation

Regulation of RIPK1 Phosphorylation: Implications for Inflammation, Cell Death, and Therapeutic Interventions

Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis

K63-linked Ubiquitination Regulates RIPK1 Kinase Activity to Prevent Cell Death During Embryogenesis and Inflammation

25 years of research put RIPK1 in the clinic

A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1

TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members

RIPK1 Dephosphorylation and Kinase Activation by PPP1R3G/PP1γ Promote Apoptosis and Necroptosis.

Regulatory mechanisms of RIPK1 in cell death and inflammation

Regulation of Innate Immune Responses by Receptor Interacting Protein Kinases (172.43)

Suppression of RIP1 activity via S415 dephosphorylation ameliorates obesity‐related hepatic insulin resistance

RIP1-Dependent and Independent Effects of Necrostatin-1 in Necrosis and T Cell Activation

Nuclear RIPK1 promotes chromatin remodeling to mediate inflammatory response